Investcorp, a leading global alternative investment firm, has announced that one of its portfolio companies has partnered with Florence Nightingale Hospital Group in Turkey to set up the region's first dedicated CAR-T stem cell therapy centre for treatment of severe leukemia, including pediatric cases.
